The Europe biobanking market was valued at USD 77.07 Billion in 2025 and is expected to grow at a CAGR of 6.89%, reaching USD 150.06 Billion by 2035. Rising investment in regenerative medicine, coupled with stringent regulatory frameworks ensuring high-quality biobanking standards, supports market growth. Increasing public awareness, collaborative research initiatives, and the integration of AI in biospecimen management are projected to boost market expansion over the coming years.
Base Year
Historical Period
Forecast Period
In June 2025, the UK Government allocated EUR 20 million to UK Biobank’s proteomics project, enabling large-scale protein analysis. This initiative is expected to significantly accelerate diagnostic research and drive growth in the market.
One of the key trends in the market is the growing collaboration across Member States. For instance, BBMRI-ERIC’s 2023 initiatives fostered transnational research, boosting infrastructure development and accelerating market growth in life sciences.
The market is witnessing steady growth, driven by increasing research activities, rising demand for personalized medicine, and strategic collaborations by key players enhancing storage technologies and biospecimen accessibility across the region.
Compound Annual Growth Rate
6.89%
Value in USD Billion
2026-2035
*this image is indicative*
Biobanking has become a cornerstone of modern biomedical research, enabling advancements in genomics, personalized medicine, and drug discovery. Europe maintains a strong position in the biobanking market, supported by stringent regulatory frameworks and expanding initiatives in genomics and population-based studies. Public-private partnerships and funding from the European Union have further stimulated market growth. The region’s focus on ethical biobanking practices and cross-border collaborations also enhances its competitive edge. The market was valued at USD 77.07 Billion in 2025, with continued momentum anticipated through the forecast period due to growing interest in translational research and precision healthcare.
Rise in Strategic Initiatives to Boost Market Growth
The implementation of BBMRI-ERIC’s 10-Year Roadmap marks a pivotal growth driver in the market. Launched in October 2024, this strategic framework emphasizes the “One Health” approach, integrating human, animal, and environmental health to elevate biobanking’s impact on research and innovation. The roadmap, co-developed with member states, national nodes, and key stakeholders, outlines eight strategic objectives aligned with scientific excellence, equity, and ethical standards. It supports harmonized national and EU-level programs, enhancing cross-border collaboration. This long-term vision significantly strengthens Europe’s biobanking infrastructure, reinforcing its market value and growth trajectory through 2035.
The market is experiencing several emerging trends, including the advancement of precision diagnostics, the integration of imaging technologies, and the growing use of AI in early neurological diagnosis.
Advancing Precision Diagnostics Imaging Integration to Elevate the Market Value
The integration of large-scale imaging datasets to enhance disease prediction and early diagnosis is a key trend shaping the market. This approach is being strengthened by initiatives like the UK Biobank’s groundbreaking whole-body imaging project. In July 2025, the program completed imaging for 100,000 participants, offering extensive insights into aging, dementia, and disease progression. By linking high-quality imaging with biological samples, biobanks are transforming clinical research and diagnostics. This trend is poised to significantly boost market growth across Europe.
AI Integration in Early Neurological Diagnosis to Impact the Biobanking Market Size Positively
The increasing integration of artificial intelligence (AI) into neurological diagnostics is emerging as a transformative trend in the market. In July 2025, researchers developed an AI algorithm capable of detecting early signs of Alzheimer’s and Parkinson’s diseases using brain scans and movement data from nearly 20,000 UK Biobank participants. This advancement highlights the growing utility of biobanked health data in AI-driven disease prediction. As AI continues to enhance early diagnostic capabilities, the demand for high-quality, well-structured biobank datasets is expected to rise, positively influencing market growth.
Human Tissues Segment to Lead the Market Share by Specimen Type
There are various types of specimens utilized in the market, including blood products, human tissues, cell lines, nucleic acids, biological fluids, human waste products, and others. Among these, the human tissues segment is expected to lead the market due to its crucial role in research areas such as oncology, regenerative medicine, and genetic studies. According to recent data, human tissues accounted for approximately 36% of the market share during the historical period. This dominance is likely to continue, driven by increasing demand for personalized medicine, advancements in tissue preservation technologies, and growing research initiatives across Europe.
The regions included in the report are the United Kingdom, Germany, France, Italy, and others. Among these, the United Kingdom is expected to lead the market, driven by its advanced infrastructure and large-scale initiatives. For instance, in March 2025, the UK Biobank launched the world’s most comprehensive proteomics study, expanding its biomedical database with protein-level data from over 600,000 samples. This groundbreaking project is expected to transform disease research, diagnostics, and drug development, reinforcing the United Kingdom’s position as a frontrunner in the European biobanking sector.
The key features of the market report comprise funding and investment analysis, and strategic initiatives by the leading players. The major companies in the market are as follows:
Thermo Fisher Scientific delivers a broad range of biobanking products and services designed to maintain biospecimen quality across every stage, from sample collection and preparation to analysis and cold storage. With innovations like ultra-low temperature freezers, cryogenic storage tubes, and cloud-based data management tools, the company plays a vital role in supporting high-integrity biobanking operations and accelerating scientific breakthroughs in life sciences.
With advanced tools like QIAwave nucleic acid extraction kits and the QIAcuityDx digital PCR system, QIAGEN plays a pivotal role in biobanking workflows. Its solutions enable precise sample preparation and molecular analysis, enhancing the value of stored biospecimens. QIAGEN supports a range of scientific domains, including forensics, cancer research, and biopharma development.
Illumina Inc. has launched a pioneering proteomics initiative in collaboration with UK Biobank and pharmaceutical leaders, utilizing its new Illumina Protein Prep™ assay. This high-throughput platform, based on SOMAmer® technology, will analyze 50,000 biological samples to uncover protein biomarkers linked to various diseases. The project underscores Illumina’s growing influence in proteogenomics and its commitment to enabling data-driven biomedical discoveries.
Avantor, Inc. delivers essential biobanking solutions through its WHEATON® brand, catering to critical research and sample preservation needs. Its portfolio includes cryogenic vials, glass ampules, color-coded storage boxes, and barcode scanning systems that streamline tracking and storage. As a global leader in life sciences, Avantor plays a key role in enabling scientific breakthroughs through efficient sample management and reliable laboratory infrastructure.
*Please note that this is only a partial list; the complete list of key players is available in the full report. Additionally, the list of key players can be customized to better suit your needs.*
Other key players in the market are Merck KGaA, STEMCELL Technologies, and Coriell Institute for Medical Research.
Europe Biobanking Market Report and Forecast 2026-2035 offers a detailed analysis of the market based on the following segments:
Market Breakup by Type
Market Breakup by Specimen Type
Market Breakup by Application
Market Breakup by Ownership
Market Breakup by End User
Market Breakup by Country
Upto 15% Off
USD
$4299 $3869
$2699 $2429
$5799 $4949
$6999 $5949
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!
Explore our key highlights of the report and gain a concise overview of key findings, trends, and actionable insights that will empower your strategic decisions.
| REPORT FEATURES | DETAILS |
| Base Year | 2025 |
| Historical Period | 2019-2025 |
| Forecast Period | 2026-2035 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Type |
|
| Breakup by Specimen Type |
|
| Breakup by Application |
|
| Breakup by Ownership |
|
| Breakup by End User |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Supplier Landscape |
|
| Companies Covered |
|
Single User License
One User
USD 4,299
USD 3,869
tax inclusive*
Datasheet
One User
USD 2,699
USD 2,429
tax inclusive*
Five User License
Five User
USD 5,799
USD 4,949
tax inclusive*
Corporate License
Unlimited Users
USD 6,999
USD 5,949
tax inclusive*
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Small Business Bundle
Growth Bundle
Enterprise Bundle
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Number of Reports: 3
20%
tax inclusive*
Small Business Bundle
Number of Reports: 5
25%
tax inclusive*
Growth Bundle
Number of Reports: 8
30%
tax inclusive*
Enterprise Bundle
Number of Reports: 10
35%
tax inclusive*
How To Order
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
Share